Project Number 1R01AG066670-01 Agency/Funding Organization NIA Funding Year 2020 View Full Project Details for Effects of Orally Administered Nicotinamide Riboside on Bioenergetic Metabolism; Oxidative Stress and Cognition in Mild Cognitive Impairment and Mild Alzheimer's Dementia Research Categorization Primary Disease / Condition Alzheimer's Disease CADRO Category C. Translational Research and Clinical Interventions 7. Early-stage Clinical Drug Development (Phase I and II Clinical Trials) j. Metabolism and Bioenergetics Researcher and Organization Principal Investigator Fei Du Principal Investigator First Name Fei Principal Investigator Last Name Du Awardee Organization McLean Hospital Awardee State Massachusetts Contact PI Country United States Project Detail Funding Opportunity Announcement PAR-18-877: Early Stage Clinical Trials for the Spectrum of Alzheimers Disease and Age-related Cognitive Decline (R01 Clinical Trial Optional) FY Overall Cost $561,552 Funding Organization Agency/Funding Organization NIA Funding Organization Country United States Program Official RYAN, LAURIE M
